Literature DB >> 2432626

Interaction of ranitidine and famotidine with guinea pig-isolated parietal cells.

K F Sewing, H Hannemann.   

Abstract

The inhibitory effects of the histamine H2-receptor antagonists, ranitidine and famotidine on histamine-stimulated gastric acid secretion have been studied in guinea pig isolated, enriched parietal cells using the 14C-aminopyrine accumulation technique. The 14C-aminopyrine accumulation curves in response to histamine were shifted towards the right in a parallel fashion by ranitidine, and in a nonparallel fashion by famotidine. The inhibitory effect of ranitidine, but not that of famotidine, was readily reversed by washing the parietal cells. It is concluded that the histamine H2-receptors in guinea pig parietal cells are blocked competitively and reversibly by ranitidine, but noncompetitively and partially reversibly by famotidine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432626     DOI: 10.1159/000138226

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

Review 1.  Comparative pharmacology of histamine H2-receptor antagonists.

Authors:  K F Sewing; W Beil; H Hannemann
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Effects of histamine and activators of the cyclic AMP system on protein synthesis in and release of high molecular weight glycoproteins from isolated gastric non-parietal cells.

Authors:  H K Heim; A Oestmann; K F Sewing
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

Review 3.  Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease.

Authors:  J G Penston; K G Wormsley
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 4.  Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  H D Langtry; S M Grant; K L Goa
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.